Simplex Trading’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $215K | Buy |
127,100
+102,900
| +425% | +$451K | ﹤0.01% | 4222 |
|
|
2025
Q4 | $125K | Buy |
24,200
+4,300
| +22% | +$22.1K | ﹤0.01% | 4742 |
|
|
2025
Q3 | $103K | Buy |
19,900
+16,000
| +410% | +$83.4K | ﹤0.01% | 5703 |
|
|
2025
Q2 | $14K | Sell |
3,900
-12,100
| -76% | -$31.3K | ﹤0.01% | 7042 |
|
|
2025
Q1 | $92K | Sell |
16,000
-6,100
| -28% | -$36.1K | ﹤0.01% | 5131 |
|
|
2024
Q4 | $110K | Buy |
22,100
+3,900
| +21% | +$20K | ﹤0.01% | 5080 |
|
|
2024
Q3 | $98K | Buy |
18,200
+7,400
| +69% | +$35.2K | ﹤0.01% | 5247 |
|
|
2024
Q2 | $35K | Buy |
10,800
+7,500
| +227% | +$29.4K | ﹤0.01% | 6400 |
|
|
2024
Q1 | $10K | Sell |
3,300
-5,300
| -62% | -$17.4K | ﹤0.01% | 7582 |
|
|
2023
Q4 | $30K | Sell |
8,600
-23,100
| -73% | -$71.3K | ﹤0.01% | 6556 |
|
|
2023
Q3 | $211K | Sell |
31,700
-45,300
| -59% | -$336K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $646K | Buy |
77,000
+13,500
| +21% | +$133K | ﹤0.01% | 3037 |
|
|
2023
Q1 | $630K | Sell |
63,500
-41,400
| -39% | -$293K | ﹤0.01% | 3038 |
|
|
2022
Q4 | $730K | Buy |
104,900
+96,200
| +1,106% | +$550K | ﹤0.01% | 2782 |
|
|
2022
Q3 | $46K | Sell |
8,700
-14,000
| -62% | -$84K | ﹤0.01% | 6550 |
|
|
2022
Q2 | $90K | Sell |
22,700
-391,000
| -95% | -$1.34M | ﹤0.01% | 5701 |
|
|
2022
Q1 | $1.84M | Buy |
413,700
+109,100
| +36% | +$435K | ﹤0.01% | 2197 |
|
|
2021
Q4 | $1.22M | Buy |
304,600
+300,000
| +6,522% | +$2.29M | ﹤0.01% | 2607 |
|
|
2021
Q3 | $52K | Hold |
4,600
| – | – | ﹤0.01% | 7460 |
|
|
2021
Q2 | $52K | Buy |
4,600
+4,560
| +11,400% | +$54.8K | ﹤0.01% | 7593 |
|
|
2021
Q1 | $47K | Sell |
40
-63
| -61% | -$725 | ﹤0.01% | 6687 |
|
|
2020
Q4 | $70K | Buy |
103
+44
| +75% | +$309 | ﹤0.01% | 5805 |
|
|
2020
Q3 | $43K | Buy |
+59
| New | +$381 | ﹤0.01% | 5745 |
|
|
2020
Q2 | – | Sell |
-44
| Closed | -$10K | – | 7518 |
|
|
2020
Q1 | $10K | Buy |
+44
| New | +$198 | ﹤0.01% | 6450 |
|
|
2019
Q4 | – | Sell |
-23
| Closed | -$12K | – | 7216 |
|
|
2019
Q3 | $12K | Sell |
23
-6
| -21% | -$32 | ﹤0.01% | 6127 |
|
|
2019
Q2 | $17K | Sell |
29
-10
| -26% | -$75 | ﹤0.01% | 5724 |
|
|
2019
Q1 | $35K | Buy |
+39
| New | +$331 | ﹤0.01% | 5276 |
|
|
2018
Q4 | – | Sell |
-146
| Closed | -$201K | – | 6913 |
|
|
2018
Q3 | $201K | Buy |
146
+142
| +3,550% | +$1.15K | ﹤0.01% | 3635 |
|
|
2018
Q2 | $3K | Buy |
+4
| New | +$32 | ﹤0.01% | 6878 |
|
Other funds holding ALDX
KCM
VCM
KCM
6CM
Simplex Trading's ALDX Position: Q1 2026 in Review
Simplex Trading sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 39,755 shares — an estimated $174K sold.
Simplex Trading first reported a position in ALDX in Q1 2018 and held it in 25 quarters. The position peaked at $810K in Q3 2018. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.
- Simplex Trading reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 39,755 Aldeyra Therapeutics shares in Q1 2026, an estimated $174K.
- Simplex Trading first reported a position in Aldeyra Therapeutics in Q1 2018 and held it in 25 quarters.
- Simplex Trading's Aldeyra Therapeutics position peaked at $810K in Q3 2018.
- 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.